These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25305029)

  • 1. Antiretroviral treatment adherence as a mediating factor between psychosocial variables and HIV viral load.
    Attonito J; Dévieux JG; Lerner BD; Hospital MM; Rosenberg R
    J Assoc Nurses AIDS Care; 2014; 25(6):626-37. PubMed ID: 25305029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
    Ironson G; O'Cleirigh C; Fletcher MA; Laurenceau JP; Balbin E; Klimas N; Schneiderman N; Solomon G
    Psychosom Med; 2005; 67(6):1013-21. PubMed ID: 16314608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of adherence to antiretroviral therapy and virologic responses in HIV-infected children, adolescents, and young adults.
    Kahana SY; Rohan J; Allison S; Frazier TW; Drotar D
    AIDS Behav; 2013 Jan; 17(1):41-60. PubMed ID: 22411426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.
    Navarro J; Pérez M; Curran A; Burgos J; Feijoo M; Torrella A; Caballero E; Ocaña I; Ribera E; Crespo M; Falcó V
    AIDS Patient Care STDS; 2014 Oct; 28(10):537-42. PubMed ID: 25111167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between alcohol use, other psychosocial factors, structural factors and antiretroviral therapy (ART) adherence among South African ART recipients.
    Morojele NK; Kekwaletswe CT; Nkosi S
    AIDS Behav; 2014 Mar; 18(3):519-24. PubMed ID: 23934270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic.
    Marconi VC; Wu B; Hampton J; Ordóñez CE; Johnson BA; Singh D; John S; Gordon M; Hare A; Murphy R; Nachega J; Kuritzkes DR; del Rio C; Sunpath H;
    AIDS Patient Care STDS; 2013 Dec; 27(12):657-68. PubMed ID: 24320011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
    Messou E; Chaix ML; Gabillard D; Minga A; Losina E; Yapo V; Kouakou M; Danel C; Sloan C; Rouzioux C; Freedberg KA; Anglaret X
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):356-64. PubMed ID: 21191309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy.
    Benning L; Mantsios A; Kerrigan D; Coleman JS; Golub E; Blackstock O; Konkle-Parker D; Philbin M; Sheth A; Adimora AA; Cohen MH; Seidman D; Milam J; Kassaye SG; Taylor T; Murray M
    BMC Womens Health; 2020 Jul; 20(1):152. PubMed ID: 32711509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.
    Coker M; Etiebet MA; Chang H; Awwal G; Jumare J; Musa BM; Babashani M; Habib AG; Dakum P; Abimiku AG; Charurat ME; Blattner WA; Eng M; Ndembi N
    Curr HIV Res; 2015; 13(4):279-85. PubMed ID: 25845393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment.
    Chohan BH; Ronen K; Khasimwa B; Matemo D; Osborn L; Unger JA; Drake AL; Beck IA; Frenkel LM; Kinuthia J; John-Stewart G
    PLoS One; 2021; 16(8):e0256249. PubMed ID: 34407133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Random forest machine learning algorithm predicts virologic outcomes among HIV infected adults in Lausanne, Switzerland using electronically monitored combined antiretroviral treatment adherence.
    Kamal S; Urata J; Cavassini M; Liu H; Kouyos R; Bugnon O; Wang W; Schneider MP
    AIDS Care; 2021 Apr; 33(4):530-536. PubMed ID: 32266825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A targeted approach for routine viral load monitoring in Malawian adults on antiretroviral therapy.
    Mungwira RG; Divala TH; Nyirenda OM; Kanjala M; Muwalo F; Mkandawire FA; Choko A; Taylor TE; Mallewa J; van Oosterhout JJ; Laufer MK; Laurens MB
    Trop Med Int Health; 2018 May; 23(5):526-532. PubMed ID: 29505108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.
    Birungi J; Cui Z; Okoboi S; Kapaata A; Munderi P; Mukajjanga C; Nanfuka M; Nyonyintono MS; Kim J; Zhu J; Kaleebu P; Moore DM
    HIV Med; 2020 Jan; 21(1):21-29. PubMed ID: 31432614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam.
    Cuong DD; Sönnerborg A; Van Tam V; El-Khatib Z; Santacatterina M; Marrone G; Chuc NT; Diwan V; Thorson A; Le NK; An PN; Larsson M
    BMC Infect Dis; 2016 Dec; 16(1):759. PubMed ID: 27986077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.
    Kehoe K; Boulle A; Tsondai PR; Euvrard J; Davies MA; Cornell M
    J Int AIDS Soc; 2020 May; 23(5):e25476. PubMed ID: 32406983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Longitudinal Effects of Non-injection Substance Use on Sustained HIV Viral Load Undetectability Among MSM and Heterosexual Men in Brazil and Thailand: The Role of ART Adherence and Depressive Symptoms (HPTN 063).
    Tsuyuki K; Shoptaw SJ; Ransome Y; Chau G; Rodriguez-Diaz CE; Friedman RK; Srithanaviboonchai K; Li S; Mimiaga MJ; Mayer KH; Safren SA
    AIDS Behav; 2019 Mar; 23(3):649-660. PubMed ID: 30725397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.
    Bonn-Miller MO; Oser ML; Bucossi MM; Trafton JA
    J Behav Med; 2014 Feb; 37(1):1-10. PubMed ID: 23054178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients.
    Sumari-de Boer IM; Sprangers MA; Prins JM; Nieuwkerk PT
    AIDS Behav; 2012 Aug; 16(6):1681-9. PubMed ID: 22198315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.